mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.035 |
0.5 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |